PPM1K-DT: A Promising Drug Target / Biomarker (G105369192)

Target Name: PPM1K-DT

NCBI ID: G105369192

PPM1K-DT

Other Name(s): PPM1K divergent transcript | PPM1K-DT variant 1 | PPM1K divergent transcript, transcript variant 1

PPM1K-DT: A Promising Drug Target / Biomarker

PPM1K-DT is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of the protein known as PDGF, which plays a crucial role in cell growth, differentiation, and survival. PPM1K-DT has also been shown to be involved in the development and progression of various diseases, including cancer. As a result, PPM1K-DT has generated a lot of interest as a potential drug target or biomarker. In this article, we will explore the biology of PPM1K-DT, its potential drug target potential, and its role in disease.

Structure and Expression:

PPM1K-DT is a 21-kDa protein that is expressed in the brain, heart, and kidneys. It is highly conserved across various species, with the highest sequence identity between human PPM1K-DT and mouse Ppm1k. PPM1K-DT is composed of a unique N-terminus, a unique C-terminus, and a unique R-terminus. The N-terminus of PPM1K-DT contains a unique farnesylated cysteine residue, which is important for its stability and localization in the brain. The C-terminus of PPM1K-DT contains a unique GXXGXXG repeats, which are also found in several other proteins. The R-terminus of PPM1K-DT contains a unique GXXGXXG repeats and a unique phosphorylated serine residue, which is important for its stability and localization in the body.

Function and Regulation:

PPM1K-DT is a key regulator of the PDGF pathway, which is a critical signaling pathway that regulates cell growth, differentiation, and survival. PDGF signaling involves the exchange of PDGF between cells, which can stimulate cell proliferation, migration, and survival. PPM1K-DT is shown to be involved in the regulation of PDGF signaling in various tissues of the body.

In addition to its role in PDGF signaling, PPM1K-DT is also involved in the regulation of cell adhesion and migration. PPM1K-DT has been shown to be involved in the regulation of tight junction formation in various tissues, including the brain. It is also involved in the regulation of cell migration in various tissues, including the brain.

Drug Target Potential:

PPM1K-DT has generated a lot of interest as a potential drug target due to its involvement in various diseases, including cancer. PPM1K-DT is a good candidate for a kinase inhibitor, which is a type of drug that inhibits the activity of protein kinases. Kinase inhibitors have been shown to be effective in treating various diseases, including cancer.

In addition to its potential as a kinase inhibitor, PPM1K-DT is also a good candidate for an inhibitor of the PDGF pathway. PDGF signaling is involved in the regulation of cell growth, differentiation, and survival, and is a potential target for various drugs. PPM1K-DT has been shown to be involved in the regulation of PDGF signaling in various tissues of the body, including the brain.

Biomarker Potential:

PPM1K-DT has also been shown to be involved in the regulation of various biological processes in the body, including cell growth, differentiation, and survival. As a result, PPM1K-DT has the potential to serve as a biomarker for various diseases, including cancer.

Conclusion:

In conclusion, PPM1K-DT is a protein that is expressed in various tissues of the body and is involved in the regulation of the PDGF pathway. It has the potential to serve as a drug target or biomarker for various diseases, including cancer. Further research is needed to fully understand the role of PPM1K-DT in various biological processes

Protein Name: PPM1K Divergent Transcript

The "PPM1K-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPM1K-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets